EdgarLookup
SC 13G/A

AMENDMENT NO. 1 TO THE SCHEDULE 13G

Company
Outlook Therapeutics, Inc.
Filed
November 7, 2024
Accession Number
0000921895-24-002509
View Document ↗ View on SEC.gov ↗